• OPEN AN ACCOUNT
Indian Indices
Nifty
24,973.10 104.50
(0.42%)
Sensex
81,425.15 323.83
( 0.40%)
Bank Nifty
54,536.00 319.90
( 0.59%)
Nifty IT
36,183.80 927.90
( 2.63%)
Global Indices
Nasdaq
45,729.90 193.94
(0.43%)
Dow Jones
6,533.40 17.25
(0.26%)
Hang Seng
43,788.68 329.39
(0.76%)
Nikkei 225
9,242.53 21.09
(0.23%)
Forex
USD-INR
88.02 -0.16
(-0.18%)
EUR-INR
103.30 -0.01
(-0.01%)
GBP-INR
119.05 -0.02
(-0.01%)
JPY-INR
0.60 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
350.4569173
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
30.94
61174.92
EPS(TTM)
Face Value()
Div & Yield %
33.74
1
0
 

Meera Industries consolidated net profit declines 68.33% in the March 2025 quarter
May 23,2025
Net profit of Meera Industries declined 68.33% to Rs 0.19 crore in the quarter ended March 2025 as against Rs 0.60 crore during the previous quarter ended March 2024. Sales declined 22.92% to Rs 7.40 crore in the quarter ended March 2025 as against Rs 9.60 crore during the previous quarter ended March 2024.

For the full year,net profit rose 154.79% to Rs 3.72 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales rose 32.22% to Rs 39.85 crore in the year ended March 2025 as against Rs 30.14 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales7.409.60 -23 39.8530.14 32
OPM %8.119.58 -14.539.82 -
PBDT0.660.91 -27 5.892.89 104
PBT0.340.59 -42 4.621.65 180
NP0.190.60 -68 3.721.46 155